Access cutting-edge respiratory syncytial virus immunization treatment through this phase 1/2 clinical trial at a research site in San Diego. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this San Diego location
Preparing your pre-screening questions…
Access respiratory syncytial virus immunization specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related respiratory syncytial virus immunization treatment provided free
Check if you qualify for this respiratory syncytial virus immunization clinical trial in San Diego, CA
No-Cost Study Care
Local to San Diego
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study is a Phase 1/2, randomized, observer-blind, active and placebo-controlled, multi-center study to be conducted in approximately 2400 adults 60 years of age and older. The aim of the study is to evaluate the immunogenicity and safety of an RSV+HMPV vaccine candidate for the prevention of RSV and HMPV disease among adults 60 years of age and older. While there are 3 FDA approved/licensed RSV vaccines currently available to the public, no vaccine is available for the prevention of HMPV in older adults. This study is intended to provide data in support of further clinical development of the RSV+HMPV vaccine candidate. The study will consist of 4 cohorts and 11 vaccine groups (RSV+HMPV \[6 dose levels\], placebo and 4 control groups). The duration of the study will be approximately 12 months for each participant.
Sponsor: Sanofi
Yes, this clinical trial (NCT07734649) has an active research site in San Diego, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for respiratory syncytial virus immunization treatment options in San Diego, CA, this clinical trial (NCT07734649) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Diego research site is actively enrolling participants for this phase 1/2 clinical trial. You'll receive care from experienced respiratory syncytial virus immunization specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all respiratory syncytial virus immunization clinical trials near you to find additional studies recruiting in your area.
See all multiple myeloma clinical trials recruiting in San Diego — not just this study.
Browse Multiple Myeloma Trials in San Diego →